Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes. 2018, Stem Cell Res Ther, 9, 56, PubMed ID: 29523209
W. Lei, T. Feng, X. Fang, Y. Yu, J. Yang, Z. A. Zhao, J. Liu, Z. Shen, W. Deng and S. Hu
Identification of circular RNAs with host gene-independent expression in human model systems for cardiac differentiation and disease. 2017, J Mol Cell Cardiol, 109, 48-56, PubMed ID: 28676412
D. Siede, K. Rapti, A. A. Gorska, H. A. Katus, J. Altmuller, J. N. Boeckel, B. Meder, C. Maack, M. Volkers, O. J. Muller, J. Backs and C. Dieterich
Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies. 2016, Trends Cardiovasc Med, 26, 663-672, PubMed ID: 27296521
S. B. Ross, S. T. Fraser and C. Semsarian
Preclinical study on induction of pluripotent stem cells from urine of dilated cardiomyopathy patients. 2016, Eur Rev Med Pharmacol Sci, 20, 1450-7, PubMed ID: 27160114
Y. H. Lin, X. M. Chen, J. W. Zhang, X. Q. He, W. J. Dai and M. S. Chen
Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. 2016, Hum Mol Genet, 25, 254-65, PubMed ID: 26604136
S. P. Wyles, X. Li, S. C. Hrstka, S. Reyes, S. Oommen, R. Beraldi, J. Edwards, A. Terzic, T. M. Olson and T. J. Nelson
Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes. 2016, Methods Mol Biol, 1353, 119-30, PubMed ID: 25690476
P. W. Burridge, S. Diecke, E. Matsa, A. Sharma, H. Wu and J. C. Wu
Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells. 2016, Methods Mol Biol, 1353, 147-62, PubMed ID: 25520292
F. Zanella and F. Sheikh
Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status. 2015, J Biomech, 48, 3890-6, PubMed ID: 26476764
Y. W. Chun, D. E. Voyles, R. Rath, L. H. Hofmeister, T. C. Boire, H. Wilcox, J. H. Lee, L. M. Bellan, C. C. Hong and H. J. Sung
Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised beta-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy. 2015, Cell Stem Cell, 17, 89-100, PubMed ID: 26095046
H. Wu, J. Lee, L. G. Vincent, Q. Wang, M. Gu, F. Lan, J. M. Churko, K. I. Sallam, E. Matsa, A. Sharma, J. D. Gold, A. J. Engler, Y. K. Xiang, D. M. Bers and J. C. Wu
Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. 2015, Dis Model Mech, 8, 457-66, PubMed ID: 25791035
B. Lin, Y. Li, L. Han, A. D. Kaplan, Y. Ao, S. Kalra, G. C. Bett, R. L. Rasmusson, C. Denning and L. Yang
Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine. 2015, Int J Mol Sci, 16, 4043-67, PubMed ID: 25689424
S. Skalova, T. Svadlakova, W. M. Shaikh Qureshi, K. Dev and J. Mokry
Human cardiac extracellular matrix supports myocardial lineage commitment of pluripotent stem cells. 2015, Eur J Cardiothorac Surg, 47, 416-25; discussion 425, PubMed ID: 24778452
B. Oberwallner, A. Brodarac, P. Anic, T. Saric, K. Wassilew, K. Neef, Y. H. Choi and C. Stamm
Modeling of human cardiomyopathy with induced pluripotent stem cells. 2014, J Biomed Nanotechnol, 10, 2562-85, PubMed ID: 25992409
Y. K. Lee, K. M. Ng and H. F. Tse
Applications of human-induced pluripotent stem cells in the investigation of inherited cardiomyopathy. 2014, Int J Cardiol, 177, 604-6, PubMed ID: 25286769
Q. Zhao, H. Cai, Y. Zhan, B. Li, S. Hu and N. Sun
Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy. 2014, Hum Mol Genet, 23, 3779-91, PubMed ID: 24584570
R. Beraldi, X. Li, A. Martinez Fernandez, S. Reyes, F. Secreto, A. Terzic, T. M. Olson and T. J. Nelson
Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. 2013, Int J Mol Sci, 14, 23086-102, PubMed ID: 24284400
M. H. Bao, X. Feng, Y. W. Zhang, X. Y. Lou, Y. Cheng and H. H. Zhou
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. 2013, Circulation, 127, 1677-91, PubMed ID: 23519760
P. Liang, F. Lan, A. S. Lee, T. Gong, V. Sanchez-Freire, Y. Wang, S. Diecke, K. Sallam, J. W. Knowles, P. J. Wang, P. K. Nguyen, D. M. Bers, R. C. Robbins and J. C. Wu
Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy. 2013, Mol Ther, 21, 1064-75, PubMed ID: 23439500
C. Catelain, S. Riveron, A. Papadopoulos, N. Mougenot, A. Jacquet, K. Vauchez, E. Yada, M. Puceat, M. Fiszman, G. Butler-Browne, G. Bonne and J. T. Vilquin
Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. 2013, Hum Mol Genet, 22, 1395-403, PubMed ID: 23300193
H. F. Tse, J. C. Ho, S. W. Choi, Y. K. Lee, A. W. Butler, K. M. Ng, C. W. Siu, M. A. Simpson, W. H. Lai, Y. C. Chan, K. W. Au, J. Zhang, K. W. Lay, M. A. Esteban, J. M. Nicholls, A. Colman and P. C. Sham
Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells. 2012, Aging (Albany NY), 4, 803-822, PubMed ID: 23362510
C. W. Siu, Y. K. Lee, J. C. Ho, W. H. Lai, Y. C. Chan, K. M. Ng, L. Y. Wong, K. W. Au, Y. M. Lau, J. Zhang, K. W. Lay, A. Colman and H. F. Tse
Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene. 2017, Stem Cell Res, 20, 88-90, PubMed ID: 28395747
S. B. Ross, S. T. Fraser, N. Nowak and C. Semsarian
Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy. 2017, Stem Cell Res, 20, 76-79, PubMed ID: 28395744
S. B. Ross, S. T. Fraser, R. D. Bagnall and C. Semsarian
Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes. 2016, J Mol Cell Cardiol, 99, 197-206, PubMed ID: 27620334
A. Monteiro da Rocha, G. Guerrero-Serna, A. Helms, C. Luzod, S. Mironov, M. Russell, J. Jalife, S. M. Day, G. D. Smith and T. J. Herron
Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes. 2016, Stem Cell Reports, 7, 355-369, PubMed ID: 27569062
R. Josowitz, S. Mulero-Navarro, N. A. Rodriguez, C. Falce, N. Cohen, E. M. Ullian, L. A. Weiss, K. A. Rauen, E. A. Sobie and B. D. Gelb
Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy. 2016, PLoS One, 11, e0146697, PubMed ID: 26784941
T. J. Cashman, R. Josowitz, B. V. Johnson, B. D. Gelb and K. D. Costa
Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function. 2015, Cell Rep, 13, 733-745, PubMed ID: 26489474
M. J. Birket, M. C. Ribeiro, G. Kosmidis, D. Ward, A. R. Leitoguinho, V. van de Pol, C. Dambrot, H. D. Devalla, R. P. Davis, P. G. Mastroberardino, D. E. Atsma, R. Passier and C. L. Mummery
Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. 2014, J Am Heart Assoc, 3, e001263, PubMed ID: 25389285
A. Tanaka, S. Yuasa, G. Mearini, T. Egashira, T. Seki, M. Kodaira, D. Kusumoto, Y. Kuroda, S. Okata, T. Suzuki, T. Inohara, T. Arimura, S. Makino, K. Kimura, A. Kimura, T. Furukawa, L. Carrier, K. Node and K. Fukuda
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. 2014, Cardiovasc Res, 104, 258-69, PubMed ID: 25209314
L. Han, Y. Li, J. Tchao, A. D. Kaplan, B. Lin, Y. Li, J. Mich-Basso, A. Lis, N. Hassan, B. London, G. C. Bett, K. Tobita, R. L. Rasmusson and L. Yang
Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes. 2014, Protein Cell, 5, 59-68, PubMed ID: 24474197
Y. Gu, G. H. Liu, N. Plongthongkum, C. Benner, F. Yi, J. Qu, K. Suzuki, J. Yang, W. Zhang, M. Li, N. Montserrat, I. Crespo, A. Del Sol, C. R. Esteban, K. Zhang and J. C. Izpisua Belmonte
Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases. 2016, Curr Opin Cardiol, 31, 266-74, PubMed ID: 27022891
A. M. Chanana, J. W. Rhee and J. C. Wu
Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy. 2017, Stem Cell Res, 20, 76-79, PubMed ID: 28395744
S. B. Ross, S. T. Fraser, R. D. Bagnall and C. Semsarian
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. 2014, Cardiovasc Res, 104, 258-69, PubMed ID: 25209314
L. Han, Y. Li, J. Tchao, A. D. Kaplan, B. Lin, Y. Li, J. Mich-Basso, A. Lis, N. Hassan, B. London, G. C. Bett, K. Tobita, R. L. Rasmusson and L. Yang
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. 2013, Circulation, 127, 1677-91, PubMed ID: 23519760
P. Liang, F. Lan, A. S. Lee, T. Gong, V. Sanchez-Freire, Y. Wang, S. Diecke, K. Sallam, J. W. Knowles, P. J. Wang, P. K. Nguyen, D. M. Bers, R. C. Robbins and J. C. Wu
)